Results 151 to 160 of about 12,991 (277)

Electron Microscopy in Renal Biopsy Interpretation: When and Why It Still Matters. [PDF]

Cureus
Qasim H, Hayajneh Z, Khattab K, Leoni MLG, Varrassi G.   +4 more
europepmc   +1 more source

Comparative 3‐Year Allograft Outcomes for Recipients of Kidneys From SARS‐CoV‐2 NAT‐Positive Donors

Transplant Infectious Disease, EarlyView.
In this retrospective single‐center study of 220 kidney transplants from SARS‐CoV‐2 NAT+, NAT+ with COVID as cause of death (CoV‐COD) and NATneg donors, we found no significant difference in rejection or kidney pathologies at 1 year, and death, graft loss, or eGFR at 3 years by CoV‐donor status.
Christine E. Koval, Mohamed Eltemamy, Nabin K. Shrestha, Leal Herlitz, Emilio D. Poggio, Alvin C. Wee   +5 more
wiley   +1 more source

A single-institution demographic study of pathologically proven kidney disease in South Korea over the last 33 years. [PDF]

J Pathol Transl Med
Noh H, Kim J, Choi YJ.
europepmc   +1 more source

Expression characteristics of dual‐specificity phosphatase 2 and hypoxia‐inducible factor‐1α in acute kidney injury and preliminary study of the effect of dual‐specificity phosphatase 2 on HK‐2 cells

Experimental Physiology, EarlyView.
ABSTRACT Acute kidney injury (AKI) is a global health problem with significant long‐term harm if the prognosis is poor. Dual‐specificity phosphatase 2 (DUSP2) is involved in key regulatory pathways in several disease processes, but its function in renal pathophysiology is unclear.
Xueqian Chu, Songmin Xue, Lanyan Lin, Xuan Huang, Sisi Chen, Wulaer Adeli, Zulibiya Tuohetiyaer, Suhua Li, Chen Lu   +8 more
wiley   +1 more source

Renal tubular lysozyme in tubulointerstitial diseases and renal sarcoidosis. [PDF]

Sarcoidosis Vasc Diffuse Lung Dis
Sanada S, Sato M.
europepmc   +1 more source

Autoimmune and Inflammatory Diseases: Identifying New Advances in Immunological Insights. [PDF]

Int J Mol Sci
Marino M, Basile U.
europepmc   +1 more source

The ERβ Agonist, OSU‐ERβ‐012, Mitigates Inflammation in a Chimeric Model of Systemic Lupus Erythematosus

ACR Open Rheumatology, Volume 8, Issue 5, May 2026.
Objective Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by multiple organ damage, affecting women between the ages of 15 and 45 years at a 9:1 rate as compared to men. The etiology of SLE is complex and elusive; however, the susceptibility of women during the years in which estrogen levels are at their highest suggests a ...
Braden Zeno, Shane Bruckner, Hongyu Yuan, Morgan Stahl, Timothy Alexandrov, Kyle Jablonski, Judith Lin, Nicholas A. Young, Wael N. Jarjour   +8 more
wiley   +1 more source

Hereditary transthyretin amyloidosis mimicking ALS: First genetically proven case report from Saudi Arabia. [PDF]

eNeurologicalSci
Elshony H, Almuhanna R, Albazli KO, Muddassir R.   +3 more
europepmc   +1 more source

Noonan Syndrome Spectrum Disorders Predispose to Systemic Lupus Erythematosus: Case Report and Critical Review of the Literature

American Journal of Medical Genetics Part A, Volume 200, Issue 5, Page 1091-1097, May 2026.
ABSTRACT RASopathies are clinically overlapping neurodevelopmental syndromes resulting from germline mutations in genes involved in the rat sarcoma/mitogen‐activated protein kinases (RAS/MAPK) pathway. Historically, RASopathies have been described by clinical phenotypes, such as Noonan syndrome and Neurofibromatosis type I.
Anastasia‐Vasiliki Madenidou, Gillian I. Rice, James O'Sullivan, Ben Parker, Ian N. Bruce, Emma Burkitt‐Wright, Tracy A. Briggs   +6 more
wiley   +1 more source

Corrigendum to "Pregnancies in Women With Kidney Failure on Home Dialysis in the United States" [<i>Kidney International Reports</i> Volume 9, Issue 4, April 2024, Pages 907-918]. [PDF]

Kidney Int Rep
Shah S, Weinhandl E, Leonard AC, Rachwal B, Verma P, Perl J, Christianson AL.   +6 more
europepmc   +1 more source